跳至主要内容
临床试验/ACTRN12615001301550
ACTRN12615001301550已完成未知

In 20 overweight post-menopausal women, the effect of boysenberry drinks are compared with inulin (positive control) and maltodextrin (placebo) on appetite and food intake.

Plant and Food Research0 个研究点目标入组 20 人开始时间: 2015年11月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 70 Years(—)
性别
Female

入选标准

  • Aged 50-70 years
  • BMI between 25 and 35 kg/m2
  • Postmenopausal defined either by age greater than 60 years; or no menopausal cycle in the past 12 months.
  • Generally healthy, as ascertained by self-report

排除标准

  • Any reported medical conditions or medications known to affect appetite -related parameters, including depression
  • Low iron status, hence unsuitable for cannulation studies
  • Participation in an active diet program and/or loss/gain of >10% body weight within the last 6 months
  • Smoker or ex-smoker who quit within the last 6 months
  • Body Mass Index greater than or equal to 35 kg/m2, or less than or equal to 25 kg/m2.
  • Reported major surgery of the GI tract, with the exception of cholecystectomy and appendectomy, in the past five years. Any major bowel resection at any time.
  • Reported history of active uncontrolled gastrointestinal disorders or diseases including: inflammatory bowel disease (IBD), ulcerative colitis), Crohn's disease or indeterminate colitis; irritable bowel syndrome (IBS) (persistent, infectious gastroenteritis, colitis or gastritis, persistent or chronic diarrhoea of unknown aetiology, Clostridium difficile infection (recurrent) or Helicobacter pylori infection (untreated); chronic and recurring constipation of >5 days.
  • Reported use of any of the following drugs within the last 6 months: systemic antibiotics (intravenous, intramuscular, or oral); corticosteroids (oral, intravenous, intramuscular, nasal or inhaled); cytokines; methotrexate or immunosuppressive cytotoxic agents;
  • Large doses of commercial probiotics consumed (greater than or equal to108 cfu or organisms per day) - includes tablets, capsules, lozenges, chewing gum or powders in which probiotic is a primary component. Ordinary dietary components such as fermented beverages/milks, yogurts, foods do not apply.
  • Acute disease at the time of enrolment (defer sampling until –participant recovers), included clinically raised blood pressure of >160/100 mm/Hg. Acute disease is defined as the presence of a moderate or severe illness with or without fever. Chronic, clinically significant (unresolved, requiring on-going medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by reported medical history
  • Reported history of cancer except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision.
  • Reported positive test for HIV, HBV or HCV.
  • Hypersensitivities or allergies to any foods or ingredients included in the study
  • Dislike and/or unwilling to consume items listed as study foods
  • Unwilling/unable to comply with study protocol
  • Participating in another clinical intervention trial

研究者

发起方
Plant and Food Research

相似试验